tiprankstipranks
Trending News
More News >
GlucoTrack (GCTK)
NASDAQ:GCTK
US Market

GlucoTrack (GCTK) Technical Analysis

Compare
198 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
GlucoTrack’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is -0.68, suggesting GlucoTrack is a Sell.
GlucoTrack’s (GCTK) 20-Day exponential moving average is 6.90, while GlucoTrack’s (GCTK) share price is $6.62, making it a Sell.
GlucoTrack’s (GCTK) 50-Day exponential moving average is 15.25, while GlucoTrack’s (GCTK) share price is $6.62, making it a Sell.

GlucoTrack (GCTK) Pivot Points

Jul 06, 2025, 05:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.65
5.90
6.21
6.46
6.77
7.02
7.33
Fibonacci
5.90
6.11
6.24
6.46
6.67
6.80
7.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

Jul 06, 2025, 05:57 PM
Period
Simple
Exponential
MA5
6.40Buy
6.45Buy
MA10
6.38Buy
6.50Buy
MA20
6.97Sell
6.90Sell
MA50
8.25Sell
15.25Sell
MA100
13.33Sell
137.34Sell
MA200
602.04Sell
715.05Sell
GlucoTrack’s (GCTK) 10-Day exponential moving average is 6.50, while GlucoTrack’s (GCTK) share price is $6.62, making it a Buy.
GlucoTrack’s (GCTK) 100-Day exponential moving average is 137.34, while GlucoTrack’s (GCTK) share price is $6.62, making it a Sell.
GlucoTrack’s (GCTK) stock price is $6.62 and GlucoTrack’s (GCTK) 50-day simple moving average is 8.25, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $6.62 and GlucoTrack’s (GCTK) 100-day simple moving average is 13.33, creating a Sell signal.
GlucoTrack’s (GCTK) stock price is $6.62 and GlucoTrack’s (GCTK) 200-day simple moving average is 602.04, creating a Sell signal.

GlucoTrack (GCTK) Technical Indicators

Jul 06, 2025, 05:57 PM
Name
Value
Implied Action
RSI (14)
45.61
Neutral
STOCH (9,6)
11.86
Buy
STOCHRSI (14)
12.35
Buy
MACD (12,26)
-0.68
Sell
ADX (14)
21.44
Neutral
Williams %R
-86.41
Buy
CCI (14)
-21.47
Neutral
ATR (14)
1.56
-
Ultimate Oscillator
28.04
Sell
ROC
4.25
Buy
GlucoTrack’s (GCTK) Relative Strength Index (RSI) is 45.61, creating a Neutral signal.
GlucoTrack’s (GCTK) Trend Strength Indicator (ADX) is 21.44, creating a Neutral signal.
GlucoTrack’s (GCTK) Commodity Channel Index (CCI) is -21.47, creating a Neutral signal.
GlucoTrack’s (GCTK) Price Rate of Change (ROC) is 4.25, creating a Buy signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Hold.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 45.61, which suggests GCTK is a Neutral.
      What is GCTK’s MACD?
      GCTK’s MACD is -0.68, which suggests GCTK is a Sell.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 6.40, which suggests GCTK is a Buy.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 6.97, which suggests GCTK is a Sell.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 8.25, which suggests GCTK is a Sell.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 602.04, which suggests GCTK is a Sell.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -86.41, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is -21.47, which suggests GCTK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis